The addition of alpelisib did not antagonize the action of ribociclib in reducing the phosphorylation of RB, but successfully suppressed the Akt signaling where its phosphorylation was abolished, which contributed to the synergistic effects in PDX tumor growth inhibitions (Fig. 4C). This evidence concerns the gene RB1 and neoplasm.